Aquestive Therapeutics (AQST) Operating Leases (2020 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Operating Leases of $4.8 million for Q1 2026, little changed year-over-year from $4.8 million in Q1 2025, and up 11.16% quarter-over-quarter from $4.3 million in Q4 2025.
Aquestive Therapeutics (AQST) Operating Leases (2020 - 2026) Analysis & Trends
Aquestive Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Operating Leases changed 0.02% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (changed 0.02% YoY), while the FY2025 annual figure was $4.3 million, down 12.7% from the prior year.
- Operating Leases for Q1 2026 stood at $4.8 million, up from $4.3 million in the prior quarter.
- The five-year high for Operating Leases was $6.0 million in Q2 2023, with the low at $1.5 million in Q2 2022.
- The 5-year median for Operating Leases is $5.1 million (2024), against an average of $4.7 million.
- The sharpest annual moves came in 2022 and 2023: Operating Leases slumped 37.81% in 2022, then jumped 296.6% in 2023.
- Aquestive Therapeutics' Operating Leases stood at $5.1 million in 2022, then increased by 6.18% to $5.4 million in 2023, then decreased by 7.98% to $5.0 million in 2024, then retreated by 12.7% to $4.3 million in 2025, then climbed by 11.16% to $4.8 million in 2026.
- Business Quant data shows AQST's Operating Leases at $4.8 million in Q1 2026, $4.3 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.35 Mn |
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Dec 31, 2024 | 4.97 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Sep 30, 2023 | 5.51 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 2.19 Mn |